The TERT genotype is not only a vital prognostic and predictive biomarker for glioma, especially for HGG [10, 11], but also a promising indicator for the sensitivity of GBM to radiotherapy and temozolomide [12]. This evidence concerns the gene TERT and glioblastoma.